Next Quarterly Earnings
Tuesday, August 11, 2026
CW 33
After-Hours
In 37 days
Supernus Pharmaceuticals develops and commercializes innovative therapies for central nervous system disorders. The company focuses on neurology and psychiatry to offer high-quality treatment options for patients with complex CNS conditions. Its core activities include research, development, and marketing of new medications aimed at improving quality of life.